We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$789M
AUM Growth
+$109M
Cap. Flow
-$27.2K
Cap. Flow %
-0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$27.2K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$336M 42.58%
8,647,398
-854
-0% -$27.2K
ODT
2
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$274M 34.74%
12,412,338
– –
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$121M 15.3%
4,138,893
– –
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
$58.2M 7.38%
2,965,485
– –

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Tang Capital Management held 4 positions worth $789M, up 16% from $680M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 0%. Tang Capital Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's biggest Q2 2018 reduction was Heron Therapeutics, cutting an estimated $27.2K.
  • Tang Capital Management's ten largest holdings make up 100% of its $789M portfolio in Q2 2018.
  • Tang Capital Management opened 0 new positions and closed 0 in Q2 2018.
  • Tang Capital Management's portfolio value rose 16% quarter-over-quarter to $789M.

Based on Tang Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.